<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34229610</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases.</ArticleTitle><Pagination><StartPage>269</StartPage><MedlinePgn>269</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">269</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-021-02298-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This article comprises a systematic review of the literature that aims at researching and analyzing the frequently applied guidelines for structuring national databases of epidemiological surveillance for motor neuron diseases, especially Amyotrophic Lateral Sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched for articles published from January 2015 to September 2019 on online databases as PubMed - U.S. National Institutes of Health's National Library of Medicine, Scopus, Science Direct, and Springer. Subsequently, we analyzed studies that considered risk factors, demographic data, and other strategic data for directing techno-scientific research, calibrating public health policies, and supporting decision-making by managers through a systemic panorama of ALS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">2850 studies were identified. 2400 were discarded for not satisfying the inclusion criteria, and 435 being duplicated or published in books or conferences. Hence, 15 articles were elected. By applying quality criteria, we then selected six studies to compose this review. Such researches featured registries from the American (3), European (2), and Oceania (1) continent. All the studies specified the methods for data capture and the patients' recruitment process for the registers.</AbstractText><AbstractText Label="DISCUSSIONS" NlmCategory="CONCLUSIONS">From the analysis of the selected papers and reported models, it is noticeable that most studies focused on the prospect of obtaining data to characterize research on epidemiological studies. Demographic data (ID01) are present in all the registries, representing the main collected data category. Furthermore, the general health history (ID02) is present in 50% of the registries analyzed. Characteristics such as access control, confidentiality and data curation. We observed that 50% of the registries comprise a patient-focused web-based self-report system.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The development of robust, interoperable, and secure electronic registries that generate value for research and patients presents itself as a solution and a challenge. This systematic review demonstrated the success of a population register requires actions with well-defined development methods, as well as the involvement of various actors of civil society.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barbalho</LastName><ForeName>Ingridy</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5696-4114</Identifier><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. ingridy.marina@lais.huol.ufrn.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentim</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. ricardo.valentim@lais.huol.ufrn.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfa;nior</LastName><ForeName>M&#xe1;rio Dourado</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Integrated Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. daniele.barros@lais.huol.ufrn.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfa;nior</LastName><ForeName>H&#xe9;rcules Pedrosa</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ Coimbra, Centre for Informatics and Systems of the University of Coimbra, Department of Informatics Engineering, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Tha&#xed;sa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Brazilian Ministry of Health, Bras&#xed;lia, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Jailton</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Institute of Rio Grande do Norte, Natal, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagem</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Technological Innovation in Health (LAIS), Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Global health</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">National databases of epidemiological</Keyword><Keyword MajorTopicYN="N">Rare disease registries</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>7</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34229610</ArticleId><ArticleId IdType="pmc">PMC8259351</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02298-2</ArticleId><ArticleId IdType="pii">10.1186/s12883-021-02298-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pagnini F, Lunetta C, Banfi P, Rossi G, Fossati F, Marconi A, Castelnuovo G, Corbo M, Molinari E. Pain in amyotrophic lateral sclerosis: a psychological perspective. Neurol Sci. 2012;33(5):1193&#x2013;6. doi: 10.1007/s10072-011-0888-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0888-6</ArticleId><ArticleId IdType="pubmed">22183268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J, Borasio G. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031&#x2013;41. doi: 10.1016/S0140-6736(07)60944-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)60944-1</ArticleId><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L, Nigel Leigh P. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4(1):3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp R, Veldink J, van den Berg LH. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;98. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman A, Gubitz A, Al-Chalabi A, Bedlack R, Berry J, Conwit R, Harris B, Horton D, Kaufmann P, Leitner M, Miller R, Shefner J, Vonsattel J, Mitsumoto H. Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(sup1):53&#x2013;61. doi: 10.3109/21678421.2013.779058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.779058</ArticleId><ArticleId IdType="pubmed">23678880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor B, Collins J, Simeone J, Goldstein L, White L. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;30. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos P, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771&#x2013;6. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K, Calvo A, Price T, Geiger J, Chi&#xf2; A, Traynor B. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila M, Longstreth W, McGuire V, Koepsell T, van Belle G. Prognosis in amyotrophic lateral sclerosis. Neurol. 2003;60(5):813&#x2013;9. doi: 10.1212/01.WNL.0000049472.47709.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva GHSd, Morais AHFd, Valentim RAdM, Dantas R, Cavalcanti L, Dourado J&#xfa;nior M. Um anjo para ela: arquitetura baseada em vis&#xe3;o computacional aplicada ao monitoramento on-line de par&#xe2;metros respirat&#xf3;rios de pacientes com esclerose lateral amiotr&#xf3;fica (ela) em ambiente hospitalar. Revista Brasileira de Engenharia Biom&#xe9;dica. 2013;29:206&#x2013;10. doi: 10.4322/rbeb.2013.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.4322/rbeb.2013.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Wicks P, Abrahams S, Masi D, Hejda-Forde S, Leigh P, Goldstein L. Prevalence of depression in a 12-month consecutive sample of patients with als. Eur J Neurol. 2007;14(9):993&#x2013;1001. doi: 10.1111/j.1468-1331.2007.01843.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2007.01843.x</ArticleId><ArticleId IdType="pubmed">17718691</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne R, Sekhon R, Johnston W, Kalra S. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2014;336(1):191&#x2013;6. doi: 10.1016/j.jns.2013.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.10.038</ArticleId><ArticleId IdType="pubmed">24239183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes F, Barbalho I, Barros D, Valentim R, Teixeira C, Henriques J, Gil P, Dourado J&#xfa;nior M. Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review. Biomed Eng OnLine. 2021;20(1):61. doi: 10.1186/s12938-021-00896-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12938-021-00896-2</ArticleId><ArticleId IdType="pmc">PMC8207575</ArticleId><ArticleId IdType="pubmed">34130692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Unal H, Rosenbohm A, Ludolph A, Rothenbacher D, Group A. Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (als)&#x2013;registry swabia. BMC Neurol. 2013;13:22. doi: 10.1186/1471-2377-13-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-22</ArticleId><ArticleId IdType="pmc">PMC3582473</ArticleId><ArticleId IdType="pubmed">23414001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye W, Sanchez M, Wu J. Feasibility of creating a national als registry using administrative data in the united states. Amyotroph Lateral Scler Frontotemporal Degeneration. 2014;15(5-6):433&#x2013;9. doi: 10.3109/21678421.2014.887119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.887119</ArticleId><ArticleId IdType="pmc">PMC4587982</ArticleId><ArticleId IdType="pubmed">24597459</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of als in canterbury, new zealand. Neurol. 2008;71(23):1889&#x2013;95. doi: 10.1212/01.wnl.0000336653.65605.ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000336653.65605.ac</ArticleId><ArticleId IdType="pubmed">19047561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K. Prevalence of amyotrophic lateral sclerosis&#x2014;united states, 2010&#x2013;2011. Morb Mortal Wkly Rep Surveill Summ. 2014;63(7):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">25054277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J, Safer A, W&#xf6;hrle J, Palm F, Nix W, Maschke M, Grau A. Factors predicting one-year mortality in amyotrophic lateral sclerosis patients - data from a population-based registry. BMC Neurol. 2014;14(1):197. doi: 10.1186/s12883-014-0197-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-014-0197-9</ArticleId><ArticleId IdType="pmc">PMC4189670</ArticleId><ArticleId IdType="pubmed">25280575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M, Vucic S, Cheah B, Turner M, Eisen A, Hardiman O, Burrell J, Zoing M. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;55. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Brayne C, Tobin K, Logroscino G, Glymour M, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurol. 2017;88(24):2321&#x2013;9. doi: 10.1212/WNL.0000000000004038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004038</ArticleId><ArticleId IdType="pubmed">28515268</ArticleId></ArticleIdList></Reference><Reference><Citation>Korngut L, Genge A, Johnston M, Benstead T, Bourque P, Briemberg H, Casey A, D&#x2019;Amour M, Dupr&#xe9; N, Figlewicz D, et al. Establishing a canadian registry of patients with amyotrophic lateral sclerosis. Can J Neurol Sci / J Can Sci Neurol. 2013;40(1):29&#x2013;35. doi: 10.1017/S0317167100012919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100012919</ArticleId><ArticleId IdType="pubmed">23250124</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliklich R, Dreyer N, Leavy M, et al. Registries for evaluating patient outcomes: a user&#x2019;s guide vol. 1. Rockville (MD): Agency for Healthcare Research and Quality (US), Gaither Road, Maryland, USA (2014). Report No.: 13(14)-EHC111. PMID: 24945055; 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">24945055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S, Logroscino G, Rooney J. The changing picture of amyotrophic lateral sclerosis: lessons from european registers. J Neurol Neurosurg Psychiatry. 2017;88(7):557&#x2013;63. doi: 10.1136/jnnp-2016-314495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314495</ArticleId><ArticleId IdType="pubmed">28285264</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Wuu J, Usher S, Ward K. Preparing for a u.s. national als registry: Lessons from a pilot project in the state of georgia. Amyotroph Lateral Scler. 2011;12(2):130&#x2013;5. doi: 10.3109/17482968.2010.515224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.515224</ArticleId><ArticleId IdType="pubmed">20843169</ArticleId></ArticleIdList></Reference><Reference><Citation>Whicher D, Philbin S, Aronson N. An overview of the impact of rare disease characteristics on research methodology. Orphanet J Rare Dis. 2018;13(1):14. doi: 10.1186/s13023-017-0755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0755-5</ArticleId><ArticleId IdType="pmc">PMC5775563</ArticleId><ArticleId IdType="pubmed">29351763</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Paz MP, Alonso V, Zurriaga O, Astray J, Aldana-Espinal J, Margolles M, Jim&#xe9;nez J, Palomar J, Santana M, Ramalle-Gomarra E, Ramos J, Arribas F, &#xc1;lamo R, Guti&#xe9;rrez-&#xc1;vila G, Galm&#xe9;s A, Ribes M, Navarro C, Errezola M, Ardanaz M, Almansa A, Garcia-Primo P, Carroquino M, Abaitua I. National rare disease registries: overview from spain. Orphanet J Rare Dis. 2014;9(1):8. doi: 10.1186/1750-1172-9-S1-O8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-9-S1-O8</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Coi A, Santoro M, Lipucci M, Bianucci A, Gainotti S, Mollo E, Vittozzi L, Taruscio D, Bianchi F. Characterization and classification of rare disease registries by using exploratory data analyses. Orphanet J Rare Dis. 2014;9(1):4. doi: 10.1186/1750-1172-9-S1-P4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-9-S1-P4</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellgard M, Beroud C, Parkinson K, Harris T, Ayme S, Baynam G, Weeramanthri T, Dawkins H, Hunter A. Dispelling myths about rare disease registry system development. Source Code Biol Med. 2013;8(1):21. doi: 10.1186/1751-0473-8-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1751-0473-8-21</ArticleId><ArticleId IdType="pmc">PMC4015362</ArticleId><ArticleId IdType="pubmed">24131574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchenham B. Procedures for performing systematic reviews. Keele University, Department of Computer Science, Software Engineering Group and Empirical Software Engineering National ICT Australia Ltd. 1.2004. p. 1&#x2013;33.</Citation></Reference><Reference><Citation>Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, Shamseer L, Tetzlaff J, Akl E, Brennan S, Chou R, Glanville J, Grimshaw J, Hr&#xf3;bjartsson A, Lalu M, Li T, Loder E, Mayo-Wilson E, McDonald S, McGuinness L, Stewart L, Thomas J, Tricco A, Welch V, Whiting P, Moher D. The prisma 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. 10.1136/bmj.n71. visited on 03.01.2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Horton D, Kasarskis E, Tessaro E, Eisenberg M, Laird S, Iskander J. Cdc grand rounds: National amyotrophic lateral sclerosis (als) registry impact, challenges, and future directions. MMWR Morb Mortal Wkly Rep. 2017;66(50):1379&#x2013;82. doi: 10.15585/mmwr.mm6650a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6650a3</ArticleId><ArticleId IdType="pmc">PMC5751576</ArticleId><ArticleId IdType="pubmed">29267263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, McCormick A, MacKenzie A, O&#x2019;Ferrall E, Venance S, Mah J, Selby K, McMillan H, Smith G, Oskoui M, Hogan G, McAdam L, Mabaya G, Hodgkinson V, Lounsberry J, Korngut L, Campbell C. The canadian neuromuscular disease registry: Connecting patients to national and international research opportunities. Paediatr Child Health. 2018;23(1):20&#x2013;6. doi: 10.1093/pch/pxx125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pch/pxx125</ArticleId><ArticleId IdType="pmc">PMC5814813</ArticleId><ArticleId IdType="pubmed">29479275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosini A, Calabrese D, Avato F, Catania F, Cavaletti G, Pera M, Toscano A, Vita G, Monaco L, Pareyson D. The italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage. Orphanet J Rare Dis. 2018;13(1):176. doi: 10.1186/s13023-018-0918-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-018-0918-z</ArticleId><ArticleId IdType="pmc">PMC6172847</ArticleId><ArticleId IdType="pubmed">30286784</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell R, Zuchner S. Movr&#x2014;neuromuscular observational research, a unified data hub for neuromuscular diseases. Genet Med. 2019;21(3):536&#x2013;8. doi: 10.1038/s41436-018-0086-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-018-0086-5</ArticleId><ArticleId IdType="pubmed">29934516</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi L-O, Kierkegaard M, Andersen P, Hillert J, Fang F, Ingre C. The swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degeneration. 2018;19(7-8):528&#x2013;37. doi: 10.1080/21678421.2018.1497065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId><ArticleId IdType="pubmed">30296856</ArticleId></ArticleIdList></Reference><Reference><Citation>SPINHOVEN P, ORMEL J, SLOEKERS P, KEMPEN G, SPECKENS A, HEMERT A. A validation study of the hospital anxiety and depression scale (hads) in different groups of dutch subjects. Psychol Med. 1997;27(2):363&#x2013;70. doi: 10.1017/S0033291796004382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291796004382</ArticleId><ArticleId IdType="pubmed">9089829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The alsfrs-r: a revised als functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E. Visual analog scale (vas) Am J Phys Med Rehabil. 2001;80(10):717. doi: 10.1097/00002060-200110000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002060-200110000-00001</ArticleId><ArticleId IdType="pubmed">11562551</ArticleId></ArticleIdList></Reference><Reference><Citation>Post M, van Leeuwen C, van Koppenhagen C, de Groot S. Validity of the life satisfaction questions, the life satisfaction questionnaire, and the satisfaction with life scale in persons with spinal cord injury. Arch Phys Med Rehabil. 2012;93(10):1832&#x2013;7. doi: 10.1016/j.apmr.2012.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2012.03.025</ArticleId><ArticleId IdType="pubmed">22484088</ArticleId></ArticleIdList></Reference><Reference><Citation>Belafsky P, Mouadeb D, Rees C, Pryor J, Postma G, Allen J, Leonard R. Validity and reliability of the eating assessment tool (eat-10) Ann Otol Rhinol Laryngol. 2008;117(12):919&#x2013;24. doi: 10.1177/000348940811701210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348940811701210</ArticleId><ArticleId IdType="pubmed">19140539</ArticleId></ArticleIdList></Reference><Reference><Citation>Prentice A, Jebb S. Beyond body mass index. Obes Rev. 2001;2(3):141&#x2013;7. doi: 10.1046/j.1467-789x.2001.00031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1467-789x.2001.00031.x</ArticleId><ArticleId IdType="pubmed">12120099</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker K, Rodrigues M, Watson B, Reilly C, Scotter E, Brunton H, Turnbull J, Roxburgh R. Establishment and 12-month progress of the new zealand motor neurone disease registry. J Clin Neurosci. 2019;60:7&#x2013;11. doi: 10.1016/j.jocn.2018.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2018.11.034</ArticleId><ArticleId IdType="pubmed">30473407</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldovino S, Moliner A, Taruscio D, Daina E, Roccatello D. Rare diseases in europe: From a wide to a local perspective. Israel Med Assoc J. 2016;18(6):359&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27468531</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>